Join
RVL Pharmaceuticals plc logo

RVLP

NASDAQ

RVL Pharmaceuticals plc

SectorHealth CareIndustryPharmaceuticals and BiotechnologyIPO2018
$0.03-0.01 (-29.51%)
News25/Ratings2

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Latest news

25 items

RVLP FAQ

7 questions
  • What does RVL Pharmaceuticals plc do?
    RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January...
  • Where does RVLP stock trade?
    RVL Pharmaceuticals plc (RVLP) is listed on NASDAQ.
  • What sector and industry is RVLP in?
    RVL Pharmaceuticals plc operates in the Health Care sector, Pharmaceuticals and Biotechnology industry.
  • When did RVL Pharmaceuticals plc go public?
    RVL Pharmaceuticals plc (RVLP) completed its IPO in 2018.
  • What are analysts saying about RVLP?
    RVL Pharmaceuticals plc has had 2 recent analyst actions on file. The most recent action was from Jefferies: Hold with a $250.00 price target on 2022-10-21. Recent price targets range from $250.00 to $400.00.
  • What companies are similar to RVLP?
    Notable peers in the same industry include EPRX (Eupraxia Pharmaceuticals Inc.), ZOM (Zomedica Corp.), HEXO (HEXO Corp.), IMV (IMV Inc.), NVCN (Neovasc Inc.). Compare RVLP side-by-side with any of them on Quantisnow.
  • How can I track RVLP on Quantisnow?
    Quantisnow aggregates RVL Pharmaceuticals plc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RVLP to receive live email and push alerts on every new disclosure.